| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb Co (BMY) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. BMY is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 204.7K | $11.58M | - | |
| CFO | 167.4K | $9.47M | - | |
| Dir | 66.1K | $3.74M | - | |
| Dir | 63.2K | $3.57M | - | |
| Dir | 38.9K | $2.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2020 | Eid Joseph | SVP,Head Glob. Medical Affairs | Sell | 5,327 | $64.00 | $340,928.00 | -67.8% | |
| Aug 13, 2020 | Leung Sandra | EVP, General Counsel | Sell | 141,420 | $63.24 | $8,943,400.80 | -24.6% | |
| Jul 9, 2020 | Celgene Corp /de/ | 10% Owner | Sell | 2,241 | $102.28 | $229,209.48 | - | |
| Jul 1, 2020 | Celgene Corp /de/ | 10% Owner | Buy | 108,108 | $92.50 | $9,999,990.00 | +1.6% | |
| Jun 15, 2020 | Paliwal Dinesh C | Director | Buy | 9,174 | $54.50 | $499,983.00 | +70.9% | |
| May 22, 2020 | Dubow Adam63 | SVP,Chiefcompliance&Ethicsoff. | Sell | 3,200 | $61.01 | $195,232.00 | -16.6% | |
| May 19, 2020 | Schmukler Louis S | EVP,Pres.,Glob.prod. &Supply | Sell | 25,000 | $62.68 | $1,567,000.00 | -48.3% | |
| Mar 4, 2020 | Elicker John E | EVP, Investor Relations | Sell | 15,805 | $61.01 | $964,263.05 | -21.2% | |
| Mar 2, 2020 | Vessey Rupert53 | Pres., Research &Early Dev. | Sale+OE | 84,308 | $60.59 | $5,108,221.72 | -63.6% | |
| Dec 5, 2019 | Dubow Adam63 | Chief Compliance &Ethics Offi | Sell | 1,740 | $58.81 | $102,329.40 | -9.9% |